Subscribe
Nadya So / Shutterstock.com
10 July 2025NewsEuropeMarisa Woutersen

Startups toolkit: Why investors want more than patents

For startups, getting a drug to market is a marathon but founders need to think beyond filing patents to win over investors, Marisa Woutersen explores how they can succeed.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
WATCH: Aligning innovation, regulation and IP protection
29 October 2024   Experts from Wilson Sonsini, Theravance Bio, Sutro Bipharma, and Addition Therapeutics share insights on managing the intersection of innovation, regulatory compliance, and IP protection in the life sciences industry.
Big Pharma
SPCs outlive patent protections in 91% of cases, new report reveals
24 June 2021   Supplementary protection certificates outlive medicinal patents in more than nine in ten cases, a new report has found.
Europe
Second medical use: a regulatory perspective
8 February 2021   Under close scrutiny by regulators, the rules around second medical use patents vary from country to country, explains Jackie Mulryne of Arnold & Porter.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Europe
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Americas
WATCH: Aligning innovation, regulation and IP protection
29 October 2024   Experts from Wilson Sonsini, Theravance Bio, Sutro Bipharma, and Addition Therapeutics share insights on managing the intersection of innovation, regulatory compliance, and IP protection in the life sciences industry.
Big Pharma
SPCs outlive patent protections in 91% of cases, new report reveals
24 June 2021   Supplementary protection certificates outlive medicinal patents in more than nine in ten cases, a new report has found.
Europe
Second medical use: a regulatory perspective
8 February 2021   Under close scrutiny by regulators, the rules around second medical use patents vary from country to country, explains Jackie Mulryne of Arnold & Porter.

More on this story

Americas
WATCH: Aligning innovation, regulation and IP protection
29 October 2024   Experts from Wilson Sonsini, Theravance Bio, Sutro Bipharma, and Addition Therapeutics share insights on managing the intersection of innovation, regulatory compliance, and IP protection in the life sciences industry.
Big Pharma
SPCs outlive patent protections in 91% of cases, new report reveals
24 June 2021   Supplementary protection certificates outlive medicinal patents in more than nine in ten cases, a new report has found.
Europe
Second medical use: a regulatory perspective
8 February 2021   Under close scrutiny by regulators, the rules around second medical use patents vary from country to country, explains Jackie Mulryne of Arnold & Porter.

More features

J&J fends off generic schizophrenia drug bids
Kilpatrick adds ‘seasoned litigator’ as trademark partner
WATCH: An update on EPO Board of Appeal strategy for 2025 and beyond
Startup challenges rival over brain monitoring tech at ITC
UKIPO rejects Boehringer’s SPC for horse inhaler
WilmerHale gains partner with ‘deep expertise’
Bayer, Orion take on Indian generic over $117bn drug
‘We created law’: G1/24 and the creation of the ‘diamond standard’